RESEARCH ARTICLE |
|
Year : 2008 | Volume
: 29
| Issue : 4 | Page : 201-206 |
|
Clinical Evaluation of 'Menorid Capsules' in the Management of Menopausal Syndrome
AK Sharma1, Rakesh Khuteta2, Anamika Soni3
1 Professor & Head, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India 2 Associate Professor, Dept. of Obs. & Gynae., S.M.S. Medical college & Hospital, S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India 3 M.D. (Ay.) Scholar, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan), India
Correspondence Address:
A K Sharma Professor & Head, P.G. Dept. of Kayachikitsa, National Institute of Ayurveda and S.M.S. Medical College & Hospital, Jaipur - 302002 (Rajasthan) India
 Source of Support: None, Conflict of Interest: None  | Check |

|
|
The study was conducted for the clinical evaluation of 'Menorid Capsules' (A Proposed Herbomineral formulation) in the management of Menopausal Syndrome on various scientific parameters. Thirty clinically diagnosed cases were selected from O.P.D. / I.P.D. of the National Institute of Ayurveda Hospital, Jaipur and S.M.S. Medical College attached Hospital, Mahila Chikitsalaya, Jaipur. The cases were randomly divided into three groups - Group I (Control Group - Oral Conjugated equine estrogen), Group II (Trial group - Menorid Capsules) and Group III (Placebo group - Capsules filled with Starch). It was observed that overall clinical improvement was maximum in patients of Group II. Overall improvement in Laboratory parameters was maximum in patients of Group I. Patients of Group III developed mild improvement in the feeling of wellbeing. The patients of Group I developed some adverse symptoms, but no adverse effects were reported in any of the patients of the Group II & III. From the current research project, it can be concluded that the trial drug 'Menorid capsules' is a safe, dependable and cost effective remedy for the management of the patients of Menopausal Syndrome. |
|
|
|
[PDF Not available]* |
|
 |
|